Brown-Forman: 99 Problems, But Weight-Loss Drugs Ain’t One
Brown-Forman faces declining organic EBIT and uneven ready-to-drink sales, while U.S.
NYSE
Brown Forman CORP
BF-A
1 story
$12B Market cap · 2026-10-09
NYSE
BF-A
1 story
$12B Market cap · 2026-10-09
Brown-Forman faces declining organic EBIT and uneven ready-to-drink sales, while U.S.